» Articles » PMID: 36297208

Making a Comeback: Syphilitic Hepatitis in a Patient with Late Latent Syphilis-Case Report and Review of the Literature

Overview
Journal Pathogens
Date 2022 Oct 27
PMID 36297208
Authors
Affiliations
Soon will be listed here.
Abstract

infection has emerged in recent years as an important community threat and burden to the health care system. Here, we report the case of a patient with cholestatic liver disease secondary to late latent syphilis. A 41 year-old male patient was referred to the clinic for assessment of an abnormal liver function panel. Ultrasound of the abdomen demonstrated an intense liver echogenicity, normal bile ducts, and no ascites. Virologic study revealed negative results for antibodies against common viral hepatitis and metabolic and autoimmune disease. The patient was tested for syphilis and a positive result was reported. The patient was diagnosed with late latent syphilis and syphilitic hepatitis and initiated benzathine penicillin at G 7.2 million units total, delivered as three doses of 2.4 million units intramuscular each at one-week intervals. He was assessed monthly and by the end of the sixth month, he had nonreactive VDRL (seroconversion), which confirmed recovery. Syphilitic hepatitis is an overlooked type of hepatitis and should be kept in mind as a differential diagnosis in an abnormal liver panel of uncertain etiology. Health care providers should be advised that higher levels of ALP may be the single landmark in cases of syphilitic hepatitis.

Citing Articles

An Uncommon Manifestation of a Great Imitator: Gummatous Syphilis of the Liver in an HIV-Positive Patient.

Solomon N, Heller T, Manciulli T, Del Giacomo P, de Gaetano Donati K, Brunetti E Case Rep Infect Dis. 2024; 2024:6571155.

PMID: 39474163 PMC: 11519062. DOI: 10.1155/2024/6571155.


Mucocutaneous relapse during late latent syphilis as initial presentation of HIV infection.

Pipito L, Russotto I, Arena D, Cala C, Cascio A IDCases. 2024; 37:e02062.

PMID: 39253400 PMC: 11382317. DOI: 10.1016/j.idcr.2024.e02062.

References
1.
Huang J, Lin S, Wan B, Zhu Y . A Systematic Literature Review of Syphilitic Hepatitis in Adults. J Clin Transl Hepatol. 2018; 6(3):306-309. PMC: 6160304. DOI: 10.14218/JCTH.2018.00003. View

2.
Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad L . Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019; 97(8):548-562P. PMC: 6653813. DOI: 10.2471/BLT.18.228486. View

3.
Rubio-Tapia A, Hujoel I, Smyrk T, Poterucha J . Emerging secondary syphilis presenting as syphilitic hepatitis. Hepatology. 2016; 65(6):2113-2115. DOI: 10.1002/hep.28974. View

4.
Luo Y, Xie Y, Xiao Y . Laboratory Diagnostic Tools for Syphilis: Current Status and Future Prospects. Front Cell Infect Microbiol. 2021; 10:574806. PMC: 7897658. DOI: 10.3389/fcimb.2020.574806. View

5.
Tiecco G, Degli Antoni M, Storti S, Marchese V, Foca E, Torti C . A 2021 Update on Syphilis: Taking Stock from Pathogenesis to Vaccines. Pathogens. 2021; 10(11). PMC: 8620723. DOI: 10.3390/pathogens10111364. View